www.fdanews.com/articles/84719-idm-and-genesis-pharma-sign-an-exclusive-marketing-agreement-for-junovan-in-south-east-europe
IDM AND GENESIS PHARMA SIGN AN EXCLUSIVE MARKETING AGREEMENT FOR JUNOVAN IN SOUTH EAST EUROPE
February 21, 2006
IDM Pharma, Inc. today announced that its subsidiary, IDM S.A., has signed an exclusive licensing and marketing agreement for Junovan in South East Europe with GENESIS Pharma, a privately owned Greek pharmaceutical company. These countries (Greece, Cyprus, Bulgaria, Croatia, Former Yugoslavian Republic Of Macedonia, Romania and Slovenia) represent approximately 50 million inhabitants.
INS News (http://feed.insnews.org/v-cgi/feeds.cgi?feedid=150&story_id=1627803)